Animal models for mucopolysaccharidosis disorders and their clinical relevance.
about
Therapeutic approaches for lysosomal storage diseasesSubstrate deprivation therapy: a new hope for patients suffering from neuronopathic forms of inherited lysosomal storage diseases.Excessive activity of cathepsin K is associated with cartilage defects in a zebrafish model of mucolipidosis II.Delayed hypertrophic differentiation of epiphyseal chondrocytes contributes to failed secondary ossification in mucopolysaccharidosis VII dogsAssessment of bone dysplasia by micro-CT and glycosaminoglycan levels in mouse models for mucopolysaccharidosis type I, IIIA, IVA, and VIIAltered olfactory epithelial structure and function in feline models of mucopolysaccharidoses I and VI.Clinical neurogenetics: neuropathic lysosomal storage disorders.Pathogenesis and treatment of spine disease in the mucopolysaccharidoses.Mucopolysaccharidosis IIIB (Sanfilippo syndrome B) in a commercial emu (Dromaius novaehollandiae) flock.Intracerebroventricular transplantation of human bone marrow-derived multipotent progenitor cells in an immunodeficient mouse model of mucopolysaccharidosis type I (MPS-I).Histopathologic changes of the ear in canine models of mucopolysaccharidosis types I and VII.
P2860
Q34311420-8F824E17-14EE-492B-85AF-167E3774F5E9Q34584825-C4C8B22C-1A1C-4F19-B4A2-956A5FD9470EQ35794555-25E9783F-5E82-4247-B900-4F066033F2C3Q36269377-297AA5AE-F190-4878-BF31-C7576C75C149Q36674929-246C5BD9-9B30-420D-8602-CE151A84296DQ36936486-9552F747-072C-4656-BC49-028FB4CA68C4Q37705073-E1AA7FC9-9C17-4DB8-9A95-80314D4E5655Q38853824-CAD1B852-3272-4B2B-8FBC-7A0F73C7D657Q47948775-8EB9FDD5-CD34-4100-8D89-2A8AA2FAB055Q48585796-8BCA8E95-F5E4-4C5B-9C71-3D362FC556B8Q50436309-ABE97C6D-59F6-4609-957D-7AE1DE810093
P2860
Animal models for mucopolysaccharidosis disorders and their clinical relevance.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Animal models for mucopolysaccharidosis disorders and their clinical relevance.
@ast
Animal models for mucopolysaccharidosis disorders and their clinical relevance.
@en
type
label
Animal models for mucopolysaccharidosis disorders and their clinical relevance.
@ast
Animal models for mucopolysaccharidosis disorders and their clinical relevance.
@en
prefLabel
Animal models for mucopolysaccharidosis disorders and their clinical relevance.
@ast
Animal models for mucopolysaccharidosis disorders and their clinical relevance.
@en
P2860
P1433
P1476
Animal models for mucopolysaccharidosis disorders and their clinical relevance.
@en
P2093
Mark E Haskins
P2860
P356
10.1111/J.1651-2227.2007.00211.X
P407
P577
2007-04-01T00:00:00Z